Atropine Sulfate Injection, Solution
Product Images NDC 63323-580

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 63323-580). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Atropine Structure)

Chemical structure of atropine sulfate, showing the molecular arrangement typical for the sulfate salt form, including the two atropine units and associated sulfate and water molecules.*

FDA Label Image

Logo (Fk Logo)

FDA Label Image

Tray (Tray)

Atropine Sulfate Injection, USP, 0.4 mg per mL (8 mg per 20 mL) in a multiple-dose vial. The label indicates it is for intravenous, intramuscular, subcutaneous, intraosseous, or endotracheal use. The packaging shows a quantity of 10 vials of 20 mL each and is labeled for prescription use only.*

FDA Label Image

Vial (Vial)

Atropine Sulfate Injection, USP label showing strength 0.4 mg/mL (8 mg per 20 mL) in a 20 mL multiple dose vial. The label specifies use via intravenous, intramuscular, subcutaneous, intraosseous, or endotracheal routes. Labeler is Fresenius Kabi USA, LLC. Product NDC 63323-580.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.